HLA-B influences integrin beta-1 expression and pancreatic cancer cell migration.

[1]  R. Postier,et al.  ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells. , 2019, Gastroenterology.

[2]  Hsin‐Yi Wu,et al.  Blockade of ITGA2 Induces Apoptosis and Inhibits Cell Migration in Gastric Cancer , 2018, Biological Procedures Online.

[3]  E. Yang,et al.  ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage , 2017, The Journal of Biological Chemistry.

[4]  G. Prager,et al.  Integrins in the Spotlight of Cancer , 2016, International journal of molecular sciences.

[5]  David H Perlman,et al.  Cryptic protein-protein interaction motifs in the cytoplasmic domain of MHCI proteins , 2016, BMC Immunology.

[6]  D. Weaver,et al.  Targeting Focal Adhesion Kinase Renders Pancreatic Cancers Responsive to Checkpoint Immunotherapy , 2016, Nature Medicine.

[7]  S. Batra,et al.  FAK and paxillin, two potential targets in pancreatic cancer , 2016, Oncotarget.

[8]  Alice Nomura,et al.  Minnelide effectively eliminates CD133+ side population in pancreatic cancer , 2015, Molecular Cancer.

[9]  J. Meza,et al.  Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis , 2014, Oncotarget.

[10]  M. Ginsberg,et al.  Integrin activation , 2014, BMB reports.

[11]  Sandra Carvalho,et al.  Pancreatic Cancer Cell Glycosylation Regulates Cell Adhesion and Invasion through the Modulation of α2β1 Integrin and E-Cadherin Function , 2014, PloS one.

[12]  Subbaya Subramanian,et al.  Triptolide Induces the Expression of miR-142-3p: A Negative Regulator of Heat Shock Protein 70 and Pancreatic Cancer Cell Proliferation , 2013, Molecular Cancer Therapeutics.

[13]  E. Reed,et al.  HLA class I: an unexpected role in integrin β4 signaling in endothelial cells. , 2012, Human immunology.

[14]  E. Reed,et al.  HLA class I antibody-mediated endothelial and smooth muscle cell activation , 2012, Current opinion in organ transplantation.

[15]  Elaine C. Campbell,et al.  The multi‐faceted nature of HLA class I dimer molecules , 2012, Immunology.

[16]  Sharmeela Kaushal,et al.  Knockdown of the β1 integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis , 2011, International journal of cancer.

[17]  Elaine C. Campbell,et al.  Expression of MHC class I dimers and ERAP1 in an ankylosing spondylitis patient cohort , 2011, Immunology.

[18]  T. MacDonald,et al.  Characterization of signaling function and expression of HLA class I molecules in medulloblastoma , 2011, Journal of Neuro-Oncology.

[19]  E. Reed,et al.  HLA Class I Molecules Partner with Integrin β4 to Stimulate Endothelial Cell Proliferation and Migration , 2010, Science Signaling.

[20]  M. Antonoff,et al.  Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways. , 2010, Gastroenterology.

[21]  C. Stipp.  Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets , 2010, Expert Reviews in Molecular Medicine.

[22]  Mahak Sharma,et al.  Mechanism for Amyloid Precursor-like Protein 2 Enhancement of Major Histocompatibility Complex Class I Molecule Degradation* , 2009, The Journal of Biological Chemistry.

[23]  T. MacDonald,et al.  Journal of Translational Medicine a Novel Role of Hla Class I in the Pathology of Medulloblastoma , 2022 .

[24]  D. Bentrem,et al.  Apigenin Inhibits the GLUT-1 Glucose Transporter and the Phosphoinositide 3-Kinase/Akt Pathway in Human Pancreatic Cancer Cells , 2008, Pancreas.

[25]  P. Singh,et al.  Phosphorylation of MUC1 by Met Modulates Interaction with p53 and MMP1 Expression* , 2008, Journal of Biological Chemistry.

[26]  Evan T. Keller,et al.  Type I collagen receptor (α2β1) signaling promotes prostate cancer invasion through RhoC GTPase , 2008 .

[27]  K. O’Connor,et al.  Integrin α6β4 Promotes Migration, Invasion through Tiam1 Upregulation, and Subsequent , 2008 .

[28]  S. Kitano,et al.  Clinical significance of HLA class I heavy chain expression in patients with gastric cancer , 2008, Journal of surgical oncology.

[29]  M. Zutter,et al.  Collagen receptor integrins: rising to the challenge. , 2008, Current drug targets.

[30]  Jason C. Ho,et al.  The Integrin-Extracellular Matrix Axis in Pancreatic Cancer , 2007, Pancreas.

[31]  M. Casas,et al.  Effect of enteral versus parenteral nutrition on inflammatory markers in severe acute pancreatitis. , 2007, Pancreas.

[32]  P. Singh,et al.  Platelet-derived growth factor receptor beta-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells. , 2007, Cancer research.

[33]  H. Pandha,et al.  Loss of expression of antigen‐presenting molecules in human pancreatic cancer and pancreatic cancer cell lines , 2007, Clinical and experimental immunology.

[34]  S. Ferrone,et al.  Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival? , 2006, Cancer Immunology, Immunotherapy.

[35]  P. Singh,et al.  RNA Interference Suppression of MUC1 Reduces the Growth Rate and Metastatic Phenotype of Human Pancreatic Cancer Cells , 2006, Clinical Cancer Research.

[36]  M. Bouvet,et al.  The α2β1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines , 2006, British Journal of Cancer.

[37]  D. Ito,et al.  Clinical Significance of Focal Adhesion Kinase in Resectable Pancreatic Cancer , 2006, World Journal of Surgery.

[38]  I. Ellis,et al.  Total loss of MHC class I is an independent indicator of good prognosis in breast cancer , 2005, International journal of cancer.

[39]  T. Adrian,et al.  LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice. , 2005, Neoplasia.

[40]  E. Danen.  Integrins: regulators of tissue function and cancer progression. , 2005, Current pharmaceutical design.

[41]  M. Büchler,et al.  Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[42]  H. Friess,et al.  Loss of heterozygosity in the HLA class I region in human pancreatic cancer. , 2004, Tissue antigens.

[43]  Wenjun Guo,et al.  Integrin signalling during tumour progression , 2004, Nature Reviews Molecular Cell Biology.

[44]  Y. Maehara,et al.  Role of Expression of Focal Adhesion Kinase in Progression of Hepatocellular Carcinoma , 2004, Clinical Cancer Research.

[45]  R. Kalluri,et al.  Integrin α1β1 and α2β1 Are the Key Regulators of Hepatocarcinoma Cell Invasion Across the Fibrotic Matrix Microenvironment , 2003 .

[46]  M. Hollingsworth,et al.  Nuclear Association of the Cytoplasmic Tail of MUC1 and β-Catenin* , 2003, Journal of Biological Chemistry.

[47]  J. Meza,et al.  Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line. , 2003, Cancer research.

[48]  H. Sawai,et al.  Interleukin-1α Enhances Integrin α6β1 Expression and Metastatic Capability of Human Pancreatic Cancer , 2003, Oncology.

[49]  H. Kuwano,et al.  FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma , 2003, British Journal of Cancer.

[50]  O. Pertz,et al.  E-cadherin is a ligand for integrin α2β1 , 2002 .

[51]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[52]  M. Hollingsworth,et al.  Overexpression of MUC1 reconfigures the binding properties of tumor cells , 2001, International journal of cancer.

[53]  S. Gout,et al.  RhoA-dependent switch between alpha2beta1 and alpha3beta1 integrins is induced by laminin-5 during early stage of HT-29 cell differentiation. , 2001, Molecular biology of the cell.

[54]  M. Ogawa,et al.  Elastase activity enhances the adhesion of neutrophil and cancer cells to vascular endothelial cells. , 2000, The Journal of surgical research.

[55]  S. Weed,et al.  Focal Adhesion Kinase: a regulator of focal adhesion dynamics and cell movement , 2000, Oncogene.

[56]  M. Hollingsworth,et al.  Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti‐adhesion molecule , 2000, International journal of cancer.

[57]  Li Zhang,et al.  Ligand Binding to Integrins* , 2000, The Journal of Biological Chemistry.

[58]  G. Mizejewski,et al.  Role of integrins in cancer: survey of expression patterns. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[59]  M. Hollingsworth,et al.  Oligosaccharides Expressed on MUC1 Produced by Pancreatic and Colon Tumor Cell Lines* , 1997, The Journal of Biological Chemistry.

[60]  J. Guan,et al.  Phosphorylation of Tyrosine 397 in Focal Adhesion Kinase Is Required for Binding Phosphatidylinositol 3-Kinase* , 1996, The Journal of Biological Chemistry.

[61]  A. Scarpa,et al.  Expression of MHC class I and class II antigens in pancreatic adenocarcinomas. , 1996, Tissue antigens.

[62]  M. Humphries,et al.  Integrin alpha 2 I-domain is a binding site for collagens. , 1995, Journal of cell science.

[63]  B. Carreno,et al.  Exogenous peptide ligand influences the expression and half‐life of free HLA class I heavy chains ubiquitously detected at the cell surface , 1994, European journal of immunology.

[64]  Takeshi Iwamura,et al.  Heterogeneities of attachment, chemotaxis, and protease production among clones with different metastatic potentials from a human pancreatic cancer cell line , 1994, Clinical & Experimental Metastasis.

[65]  T. Suganuma,et al.  Extracellular matrix components regulating glandular differentiation and the formation of basal lamina of a human pancreatic cancer cell line in vitro. , 1994, Experimental cell research.

[66]  J. Parsons,et al.  Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src , 1994, Molecular and cellular biology.

[67]  J. Parsons,et al.  Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK , 1994, Molecular and cellular biology.

[68]  T. Iwamura,et al.  Correlation between spontaneous metastatic potential and type I collagenolytic activity in a human pancreatic cancer cell line (SUIT-2) and sublines , 1992, Clinical & Experimental Metastasis.

[69]  H. Ploegh,et al.  HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. , 1990, International immunology.

[70]  H. Ljunggren,et al.  Association of class I major histocompatibility heavy and light chains induced by viral peptides , 1989, Nature.

[71]  B. Benacerraf.  Role of MHC gene products in immune regulation. , 1981, Science.

[72]  H. Orr,et al.  Assembly and maturation of HLA-A and HLA-B antigens in vivo , 1979, Cell.

[73]  A. Yunis,et al.  Human pancreatic carcinoma (mia paca‐2) in continuous culture: Sensitivity to asparaginase , 1977, International journal of cancer.

[74]  M. Lieber,et al.  Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas , 1975, International journal of cancer.

[75]  Jie J. Zheng,et al.  ReviewPDZ domains and their binding partners : structure , specificity , and modification , 2015 .

[76]  Elaine C. Campbell,et al.  The MHC Class I heavy chain structurally conserved cysteines 101 and 164 participate in HLA-B27 dimer formation. , 2012, Antioxidants & redox signaling.

[77]  R. Kalluri,et al.  Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. , 2003, Cancer research.

[78]  E Ruoslahti,et al.  Integrin signaling. , 1999, Science.